Invo Bioscience Earns CE Mark for Fertility Device

Invo Bioscience has earned the CE Mark for its InvoCell culture and retention device as an alternative to traditional in vitro fertilization treatment.

The device allows egg fertilization and early embryo development to occur inside a woman’s body. The procedure is half the cost of traditional in vitro fertilization treatment, the company said.

The product previously received the FDA’s de novo approval in November 2015 and hit the U.S. market in April 2016.